HVT vs RCUS vs ETH vs AGEN vs NKTR

For growth investors, Agenus Inc.

(AGEN) is the stronger pick with 10. 4% revenue growth year-over-year, versus -43. 9% for Nektar Therapeutics (NKTR). Grayscale Ethereum Mini Trust (ETH) offers the better valuation at 10. 8x trailing P/E (8. 5x forward), making it the more compelling value choice. Analysts rate Haverty Furniture Companies, Inc. (HVT) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Grayscale Ethereum Mini Trust (ETH) is the cheapest at 10.

8x versus Haverty Furniture Companies, Inc. at 18. 3x. On forward P/E, Agenus Inc. is actually cheaper at 1. 8x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Arcus Biosciences, Inc.

(RCUS) delivered a total return of -18. 6%, compared to -93. 9% for Agenus Inc. (AGEN). Over 10 years, the gap is even starker: HVT returned +109. 8% versus AGEN's -94. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Haverty Furniture Companies, Inc.

(HVT) is the lower-risk stock at 1. 14β versus Grayscale Ethereum Mini Trust's 2. 91β — meaning ETH is approximately 156% more volatile than HVT relative to the S&P 500. On balance sheet safety, Arcus Biosciences, Inc. (RCUS) carries a lower debt/equity ratio of 16% versus 166% for Nektar Therapeutics — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Agenus Inc.

(AGEN) is pulling ahead at 10. 4% versus -43. 9% for Nektar Therapeutics (NKTR). On earnings-per-share growth, the picture is similar: Agenus Inc. grew EPS 100. 0% year-over-year, compared to -19. 3% for Grayscale Ethereum Mini Trust. Over a 3-year CAGR, RCUS leads at 30. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Grayscale Ethereum Mini Trust (ETH) is the more profitable company, earning 8.

4% net margin versus -297. 1% for Nektar Therapeutics — meaning it keeps 8. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ETH leads at 10. 1% versus -236. 8% for NKTR. At the gross margin level — before operating expenses — NKTR leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Agenus Inc.

(AGEN) trades at 1. 8x forward P/E versus 11. 6x for Haverty Furniture Companies, Inc. — 9. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AGEN: 95. 5% to $7. 33.

In this comparison, HVT (5.

8% yield) pays a dividend. RCUS, ETH, AGEN, NKTR do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Haverty Furniture Companies, Inc.

(HVT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 14), 5. 8% yield, +109. 8% 10Y return). Agenus Inc. (AGEN) carries a higher beta of 2. 72 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HVT: +109. 8%, AGEN: -94. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (HVT (Consumer Cyclical) and RCUS (Healthcare) and ETH (Financial Services) and AGEN (Healthcare) and NKTR (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: HVT is a small-cap income-oriented stock; RCUS is a small-cap quality compounder stock; ETH is a small-cap deep-value stock; AGEN is a small-cap quality compounder stock; NKTR is a small-cap quality compounder stock. HVT pays a dividend while RCUS, ETH, AGEN, NKTR do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.